These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 19027288)

  • 21. Markers of apoptosis in stage IB squamous cervical carcinoma.
    Van de Putte G; Holm R; Lie AK; Baekelandt M; Kristensen GB
    J Clin Pathol; 2005 Jun; 58(6):590-4. PubMed ID: 15917408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
    Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
    Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence.
    Belt EJ; Fijneman RJ; van den Berg EG; Bril H; Delis-van Diemen PM; Tijssen M; van Essen HF; de Lange-de Klerk ES; Beliën JA; Stockmann HB; Meijer S; Meijer GA
    Eur J Cancer; 2011 Aug; 47(12):1837-45. PubMed ID: 21621406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Fas ligand and bcl-2 in cervical carcinoma and their prognostic significance.
    Munakata S; Watanabe O; Ohashi K; Morino H
    Am J Clin Pathol; 2005 Jun; 123(6):879-85. PubMed ID: 15899779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
    Sup SJ; Alemañy CA; Pohlman B; Elson P; Malhi S; Thakkar S; Steinle R; Hsi ED
    J Clin Oncol; 2005 Jun; 23(16):3773-9. PubMed ID: 15809450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
    Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronan expression in differentiated thyroid carcinoma.
    Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM
    J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.
    Oshikiri T; Hida Y; Miyamoto M; Hashida H; Katoh K; Suzuoki M; Nakakubo Y; Hiraoka K; Shinohara T; Itoh T; Kondo S; Katoh H
    Br J Cancer; 2001 Dec; 85(12):1922-7. PubMed ID: 11747335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the bcl-2 gene and its significance in human pancreatic carcinoma.
    Sun CY; Wang BL; Hu CQ; Peng RY; Gao YB; Gu QY; Wang DW
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):306-8. PubMed ID: 14612291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.
    Park KJ; Choi HJ; Roh MS; Kwon HC; Kim C
    Dis Colon Rectum; 2005 Aug; 48(8):1597-602. PubMed ID: 15937624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of bcl-2 persistence: an independent prognostic indicator of poor prognosis in endometrial carcinoma.
    Geisler JP; Geisler HE; Wiemann MC; Zhou Z; Miller GA; Crabtree W
    Gynecol Oncol; 1998 Nov; 71(2):305-7. PubMed ID: 9826476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma.
    Chen MK; Lai JC; Chang CC; Chang JH; Chang YJ; Chen HC
    Head Neck; 2008 Aug; 30(8):1052-7. PubMed ID: 18442057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma.
    Hammock L; Cohen C; Carlson G; Murray D; Ross JS; Sheehan C; Nazir TM; Carlson JA
    J Cutan Pathol; 2006 Sep; 33(9):599-607. PubMed ID: 16965333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens.
    Rubio J; Ramos D; López-Guerrero JA; Iborra I; Collado A; Solsona E; Almenar S; Llombart-Bosch A
    Eur Urol; 2005 Nov; 48(5):745-51. PubMed ID: 16139948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
    Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
    Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL).
    Hellquist HB; Sundelin K; Di Bacco A; Tytor M; Manzotti M; Viale G
    J Pathol; 1997 Mar; 181(3):323-9. PubMed ID: 9155720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of spontaneous tumour perforation on outcome following colon cancer surgery.
    Abdelrazeq AS; Scott N; Thorn C; Verbeke CS; Ambrose NS; Botterill ID; Jayne DG
    Colorectal Dis; 2008 Oct; 10(8):775-80. PubMed ID: 18266887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.